Patents/Assignees

Shuttle Pharmaceuticals, Inc.

4 patents in portfolio

US12357650utility2025
Methods and Compositions for Cancer Therapies That Include Delivery of Halogenated Thymidines and Thymidine Phosphorlylase Inhibitors in Combination with Radiation
0 cites
US12077515utility2024
Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease
0 cites
US11654157utility2023
Methods and Compositions for Cancer Therapies That Include Delivery of Halogenated Thymidines and Thymidine Phosphorylase Inhibitors in Combination with Radiation
0 cites
US11584733utility2023
Selective Histone Deacetylase Inhibitors for the Treatment of Human Disease
0 cites